Pharma behaving badly in San Diego

Miller JE. Bioethical accreditation or rating needed to restore trust in pharma Nature Medicine 19, 261 (2013) doi:10.1038/nm0313-261. ...

AAN 2013: more on the safety of oral cladribine

"The following is the safety profile of oral cladribine in the ORACLE or CIS study that was presented at the AAN." "The mos...

Alemtuzumab improves neurological function

"My second poster at the AAN today. This shows that compared to interferon-beta, alemtuzumab treatment more than doubles your chances o...

BG12 reduces requirements for steroids and hospitalisations

"My first poster today at the AAN. The data speaks for itself. Treatment with BG12 reduces the need for steroids and hospitalizations. ...

AAN 2013 San Diego: daclizumab extension study results

"The following is my platform presentation from the AAN in San Diego. I presented it yesterday afternoon. You may find the information ...